Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2009
02/12/2009US20090044297 Transgenic plants with enhanced agronomic traits
02/12/2009US20090044296 Hrpn interactors and uses thereof
02/12/2009US20090044294 Method for modifying lignin composition and increasing in vivo digestibility of forages
02/12/2009US20090044293 Plants with altered root architecture, involving the rt1 gene, related constructs and methods
02/12/2009US20090044292 Compositions and methods relating to transgenic plants and cellulosic ethanol production
02/12/2009US20090044291 Drought-resistant plants and method for producing the plants
02/12/2009US20090044290 Salt resistant transgenic plants
02/12/2009US20090044289 Nucleic acid molecules and their use in plant sterility
02/12/2009US20090044288 Transgenic plants with enhanced agrnomic traits
02/12/2009US20090044287 Compositions and methods for drought tolerance
02/12/2009US20090043087 DNA purification and recovery from high particulate and solids samples
02/12/2009US20090043085 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
02/12/2009US20090043083 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
02/12/2009US20090043082 Microrna and methods for inhibiting same
02/12/2009US20090043076 Modified interferon beta with reduced immunogenicity
02/12/2009US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof
02/12/2009US20090042829 Nucleic Acid-Lipopolymer Compositions
02/12/2009US20090042828 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage
02/12/2009US20090042827 Antiviral oligonucleotides targeting hbv
02/12/2009US20090042826 Use of the AXL receptor for diagnosis and treatment of renal disease
02/12/2009US20090042797 Gamma-heregulin
02/12/2009US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use
02/12/2009US20090042795 Cardiac stem cell proliferation proteins, fragments thereof and methods of modulating stem cell proliferation and differentiation
02/12/2009US20090042794 Group b streptococcus antigens and corresponding dna fragments
02/12/2009US20090042792 18 human secreted proteins
02/12/2009US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity
02/12/2009US20090042786 Kunitz-type recombinant inhibitor
02/12/2009US20090042777 G-CSF Transferrin Fusion Proteins
02/12/2009US20090042776 Fungal immunomodulatory protein (fip) prepared by microorganisms and uses thereof
02/12/2009US20090042775 Functional genomics, bioinformatics
02/12/2009US20090042738 Tyrosylprotein sulfotransferases and methods of use thereof
02/12/2009US20090042733 Process for detecting or quantifying nucleic acids in a library
02/12/2009US20090042302 Isolated Polynucleotides and Methods of Promoting a Morphology in a Fungus
02/12/2009US20090042301 Temperature regulated gene expression
02/12/2009US20090042300 Method for enhancing gene expression in plants
02/12/2009US20090042299 Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens
02/12/2009US20090042298 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
02/12/2009US20090042297 Piggybac transposon-based vectors and methods of nucleic acid integration
02/12/2009US20090042296 Transfection ready eukaryotic cells
02/12/2009US20090042285 Antibodies at T cell receptor mimics, methods of production and uses thereof
02/12/2009US20090042283 Optimized messenger rna
02/12/2009US20090042282 Preparation of protective antigen
02/12/2009US20090042278 Method of protein production in yeast
02/12/2009US20090042277 Nucleic acids encoding recombinant soluble endoproteases
02/12/2009US20090042275 Novel plasmids and utilization thereof
02/12/2009US20090042270 Activatable recombinant neurotoxins
02/12/2009US20090042266 Treatment of cellulosic material and enzymes useful thererin
02/12/2009US20090042265 Thermophilic Microorganisms with Inactivated Lactate Dehydrogenase Gene (LDH) for Ethanol Production
02/12/2009US20090042264 Compositions and methods for manipulating carbon flux in cells
02/12/2009US20090042258 Methods and Compositions for DNA Manipulation
02/12/2009US20090042254 Expression of soluble antibody fragment by truncation of ch1 domain
02/12/2009US20090042252 Interferon-alpha polypeptides and conjugates
02/12/2009US20090042251 Chimeric fusion protein
02/12/2009US20090042250 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression
02/12/2009US20090042249 Vectors for Cloning
02/12/2009US20090042248 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
02/12/2009US20090042247 N-acetylglucosaminyltransferase vb coding sequences, recombinant cells and methods
02/12/2009US20090042246 Methods For The Production And Secretion Of Modified Peptides
02/12/2009US20090042244 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents
02/12/2009US20090042226 Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer)
02/12/2009US20090042216 Method for purifying proteins and/or biomolecule or protein complexes
02/12/2009US20090042212 Detection of primary infections with pathogens
02/12/2009US20090042207 INTRACELLULAR EXPRESSION AND DELIVERY OF siRNAs IN MAMMALIAN CELLS
02/12/2009US20090042203 Digesting a target nucleic acid molecule; capturing digested fragments on a solid support that containing oligonucleotides complementary, detecting hybrids and molecular weight of captured fragments by mass spectrometry to identify mutations; Fast and highly accurate
02/12/2009US20090042202 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
02/12/2009US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection
02/12/2009US20090042192 Universal amplification of fragmented rna
02/12/2009US20090042188 Agent for Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Comprising Vdup1 Protein or Gene Encoding the Same, and a Method of Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Using Thereof
02/12/2009US20090042181 Expresion vector comprising hepatitis C viral sequences for use in development and evaluation of antiviral drugs; drug screening
02/12/2009US20090041899 Recombinant hexose oxidase, a method of producing same and use of such enzyme
02/12/2009US20090041896 Use in treatment of paper pulp or animal feeds; enzyme is active over a wide range of temperature and of basic and acid pH
02/12/2009US20090041891 Gene Encoding Transcriptional Inducer for Maltase Gene and Maltose Transporter Gene and use Thereof
02/12/2009US20090041889 Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof
02/12/2009US20090041887 High Protein Soybean Meal
02/12/2009US20090041869 Method of reducing insect resistant pests in transgenic crops
02/12/2009US20090041862 Detecting disease association with aberrant glycogen synthase kinase 3beta expression
02/12/2009US20090041809 Double-stranded locked nucleic acid compositions
02/12/2009US20090041804 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigens), intercellular adhesion molecules and leukocyte function associated antigen-3
02/12/2009US20090041794 Identification of Hla-A2-Presented T-Cell Epitopes Derived from the Oncofoetal Antigen-Immature Laminin Receptor Protein and Uses Thereof
02/12/2009US20090041793 Immunostimulatory Compositions and Uses Thereof
02/12/2009US20090041784 Compositions and methods relating to glucagon receptor antibodies
02/12/2009US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody
02/12/2009US20090041782 Novel serotype streptococcus mutans and utilization of the same
02/12/2009US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening
02/12/2009US20090041776 Production of cancer-specific antibodies in plants
02/12/2009US20090041774 Haemophilus influenzae type IV pili
02/12/2009US20090041772 Soluble Forms of Hendra and Nipah Virus G Glycoprotein
02/12/2009US20090041769 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis
02/12/2009US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof
02/12/2009US20090041759 Materials and methods for treating ocular-related disorders
02/12/2009US20090041758 Modified binding molecules comprising connecting peptides
02/12/2009US20090041756 121p1f1: a tissue specific protein highly expressed in various cancers
02/12/2009US20090041742 Human dnase ii
02/12/2009US20090041740 Cancer treatment by metabolic modulations
02/12/2009US20090041726 Tumor therapy with high affinity laminin receptor-target vectors and combinations with chemotherapeutic agents
02/12/2009US20090041725 Replication-Deficient RNA Viruses as Vaccines
02/12/2009US20090041724 Protein Delivery System
02/12/2009US20090041717 High affinity human antibodies to human nerve growth factor
02/12/2009US20090041679 Human neutralizing monoclonal antibodies to h5n1 influenza a virus
02/12/2009US20090041665 Method for gene delivery to neuronal cells